Missing/wrong data?
Log in to edit
Alemtuzumab is safe and effective as immunosuppressive treatment for aplastic anaemia and single-lineage marrow failure: a pilot study and a survey from the EBMT WPSAA.
scientific article
Author/s
author: Alexander Kulagin, Vikas Gupta, Jakob R. Passweg
Work details
Publication date
December 7, 2009
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.